These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32565500)

  • 21. Achieving the HbA1c Target Requires Longer Time in Range in Pregnant Women With Type 1 Diabetes.
    Ling P; Yang D; Gu N; Xiao X; Lu J; Liu F; Zhou Z; Huang Q; Zhao J; Zhang M; Hu J; Luo S; Weng J; Yan J; Zheng X
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4309-e4317. PubMed ID: 34244734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained Effectiveness of an Advanced Hybrid Closed-Loop System in a Cohort of Children and Adolescents With Type 1 Diabetes: A 1-Year Real-World Study.
    Passanisi S; Salzano G; Bombaci B; Minuto N; Bassi M; Bonfanti R; Scialabba F; Mozzillo E; Di Candia F; Monti S; Graziani V; Maffeis C; Piona CA; Arnaldi C; Tosini D; Felappi B; Roppolo R; Zanfardino A; Delvecchio M; Lo Presti D; Calzi E; Ripoli C; Franceschi R; Reinstadler P; Rabbone I; Maltoni G; Alibrandi A; Zucchini S; Marigliano M; Lombardo F;
    Diabetes Care; 2024 Jun; 47(6):1084-1091. PubMed ID: 38626260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous Glucose Monitoring in Adults With Type 1 Diabetes With 35 Years Duration From the DCCT/EDIC Study.
    Gubitosi-Klug RA; Braffett BH; Bebu I; Johnson ML; Farrell K; Kenny D; Trapani VR; Meadema-Mayer L; Soliman EZ; Pop-Busui R; Lachin JM; Bergenstal RM; Tamborlane WV
    Diabetes Care; 2022 Mar; 45(3):659-665. PubMed ID: 35076697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Patient-reported Satisfaction and Metabolic Outcomes Following Initiation of the Second Generation of Flash Glucose Monitoring in Patients with Type 1 Diabetes.
    Al Hayek A; Robert AA; Alzahrani WM; Al Dawish MA
    Curr Diabetes Rev; 2024; 20(4):e100823219628. PubMed ID: 37563819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous glucose monitoring metrics following sub-Tenon's injection of triamcinolone acetonide for diabetic macular edema.
    Sotani-Ogawa R; Kusuhara S; Hirota Y; Kim KW; Matsumiya W; Ogawa W; Nakamura M
    Graefes Arch Clin Exp Ophthalmol; 2024 Feb; 262(2):449-456. PubMed ID: 37864636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal Observation of Insulin Use and Glucose Sensor Metrics in Pregnant Women with Type 1 Diabetes Using Continuous Glucose Monitors and Insulin Pumps: The LOIS-P Study.
    O'Malley G; Ozaslan B; Levy CJ; Castorino K; Desjardins D; Levister C; McCrady-Spitzer S; Church MM; Kaur RJ; Reid C; Kremers WK; Doyle FJ; Trinidad MC; Rosenn B; Pinsker JE; Kudva YC; Dassau E
    Diabetes Technol Ther; 2021 Dec; 23(12):807-817. PubMed ID: 34270347
    [No Abstract]   [Full Text] [Related]  

  • 27. The Health Economics of Automated Insulin Delivery Systems and the Potential Use of Time in Range in Diabetes Modeling: A Narrative Review.
    Mathieu C; Ahmed W; Gillard P; Cohen O; Vigersky R; de Portu S; Ozdemir Saltik AZ
    Diabetes Technol Ther; 2024 Mar; 26(S3):66-75. PubMed ID: 38377319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary composition and time in range in population with type 2 diabetes mellitus-exploring the association using continuous glucose monitoring device.
    Deshmane AR; Muley AS
    Endocrine; 2024 Aug; 85(2):724-729. PubMed ID: 38514590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations Between HbA1c and Glucose Time in Range Using Continuous Glucose Monitoring in Type 1 Diabetes: Cross-Sectional Population-Based Study.
    Eliasson B; Allansson Kjölhede E; Salö S; Fabrin Nielsen N; Eeg-Olofsson K
    Diabetes Ther; 2024 Jun; 15(6):1301-1312. PubMed ID: 38598054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes.
    Fuhri Snethlage CM; McDonald TJ; Oram RD; de Groen P; Rampanelli E; Schimmel AWM; Holleman F; Siegelaar S; Hoekstra J; Brouwer CB; Knop FK; Verchere CB; van Raalte DH; Roep BO; Nieuwdorp M; Hanssen NMJ
    Diabetes Care; 2024 Jul; 47(7):1114-1121. PubMed ID: 37535870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between continuous glucose monitoring metrics and clinical outcomes in adults with type 1 diabetes in a real-world setting.
    Brett McQueen R; Perez-Nieves M; Todd Alonso G; Fan L; Hankosky ER; Shah VN; Yan Y; Ellis SL; Juneja R
    Diabetes Res Clin Pract; 2024 Jun; 212():111690. PubMed ID: 38697300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aiming for the Best Glycemic Control Beyond Time in Range: Time in Tight Range as a New Continuous Glucose Monitoring Metric in Children and Adolescents with Type 1 Diabetes Using Different Treatment Modalities.
    Passanisi S; Piona C; Salzano G; Marigliano M; Bombaci B; Morandi A; Alibrandi A; Maffeis C; Lombardo F
    Diabetes Technol Ther; 2024 Mar; 26(3):161-166. PubMed ID: 37902743
    [No Abstract]   [Full Text] [Related]  

  • 33. [Sensor-Augmented Pump Therapy: description of pediatric patients with Type 1 Diabetes Mellitus (T1D) and initial metabolic outcomes].
    Wong Lam C; Hurtado Navarro J; Fuentes Díaz R; Toro Toro E; Reyes Espejo B
    Andes Pediatr; 2022 Dec; 93(6):860-867. PubMed ID: 37906803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best Efficacy.
    Lepore G; Borella ND; Castagna G; Ippolito S; Bonfadini S; Corsi A; Scaranna C; Dodesini AR; Bellante R; Trevisan R
    Diabetes Technol Ther; 2024 Jan; 26(1):49-58. PubMed ID: 37902785
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring Systems in a Type 1 Diabetes Patient French Cohort: An Observational Study of Clinical Practices.
    Préau Y; Armand M; Galie S; Schaepelynck P; Raccah D
    Diabetes Technol Ther; 2021 Apr; 23(4):259-267. PubMed ID: 33136439
    [No Abstract]   [Full Text] [Related]  

  • 36. Safety and Efficacy of Sustained Automated Insulin Delivery Compared With Sensor and Pump Therapy in Adults With Type 1 Diabetes at High Risk for Hypoglycemia: A Randomized Controlled Trial.
    Renard E; Joubert M; Villard O; Dreves B; Reznik Y; Farret A; Place J; Breton MD; Kovatchev BP;
    Diabetes Care; 2023 Dec; 46(12):2180-2187. PubMed ID: 37729080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is It Time to Move Beyond TIR to TITR? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 Diabetes.
    Dunn TC; Ajjan RA; Bergenstal RM; Xu Y
    Diabetes Technol Ther; 2024 Mar; 26(3):203-210. PubMed ID: 38444315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of 12-Week Freestyle Libre 2.0 in Children with Type 1 Diabetes and Elevated HbA1c: A Multicenter Randomized Controlled Trial.
    Jefferies CA; Boucsein A; Styles SE; Chamberlain B; Michaels VR; Crockett HR; De Lange M; Lala A; Cunningham V; Wiltshire EJ; Serlachius AS; Wheeler BJ
    Diabetes Technol Ther; 2023 Dec; 25(12):827-835. PubMed ID: 37782139
    [No Abstract]   [Full Text] [Related]  

  • 39. Accuracy of a CGM Sensor in Pediatric Subjects With Type 1 Diabetes. Comparison of Three Insertion Sites: Arm, Abdomen, and Gluteus.
    Faccioli S; Del Favero S; Visentin R; Bonfanti R; Iafusco D; Rabbone I; Marigliano M; Schiaffini R; Bruttomesso D; Cobelli C;
    J Diabetes Sci Technol; 2017 Nov; 11(6):1147-1154. PubMed ID: 28486841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three months use of Hybrid Closed Loop Systems improves glycated hemoglobin levels in adolescents and children with type 1 diabetes: A meta-analysis.
    Wang YY; Ying HM; Tian F; Qian XL; Zhou ZF
    PLoS One; 2024; 19(8):e0308202. PubMed ID: 39133688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.